Exact FDA event identifier

Event 76742

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: March 15, 2017
Product types: Drug
Classifications: Class II
Statuses: Terminated
Recalling firm wording: Sun Pharmaceutical Industries, Inc.

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Testosterone Cypionate Injection , USP, 200 mg/mL, 1 mL vial , For Intramuscular Use Only, Rx Only, Distributed by Sun Pharma Ind. Inc., NJ 08512, Manufactured by Sun Pharma Ind. Ltd. India, NDC 62756-015-40

D-0611-2017

Recall number: D-0611-2017
Initiated: March 15, 2017
Classification: Class II
Status: Terminated
Recalling firm: Sun Pharmaceutical Industries, Inc.
Quantity: 83,188 single does vials

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0

Particulate Matter

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Presence of Particulate Matter

Code information

JKR0744A, JKR0745A, JKR0750A, JKR0795A; Exp. 09/18

Distribution pattern

Nationwide